Patent · US Active

Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

US10781251B2 · kind B2 · utility

3Cited by

1References

20Claims

0Family size

Assignee

Julius-Maximilians-Universitat Wurzburg · DE

Inventors

Jörg WISCHHUSEN · Würzburg, DE
Markus Junker · Würzburg, DE
Thomas Müller · Biberach, DE
Stefan Saremba · Würzburg, DE

Key dates

Filing date	Mar 12, 2018
Grant date	Sep 22, 2020
Priority date	—
Expiry date	May 29, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel monoclonal anti-human-GDF-15 antibodies, pharmaceutical compositions, kits, methods and uses and the cell lines capable of producing the monoclonal antibodies described herein. The present invention further relates to novel antibodies to human GDF-15 capable of inhibiting cancer growth.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.